Dr. Emre Turkmen is a specialized ENT and facial plastic surgeon at Estemarley Clinic in Istanbul. He focuses on rhinoplasty, ear aesthetics, and sinus surgery. Dr. Turkmen is an active member of the European Academy of Facial Plastic Surgery (EAFPS).
Dr. Zeynep Civelek is a general surgeon. She treats benign perianal diseases, including hemorrhoids (with laser), anal fissure, fistula, condyloma, and pilonidal disease, and performs rubber band ligation. She also manages breast disease and cancer, skin cancers, laparoscopic cholecystectomy, and hernias. She worked full-time at Bayindir Levent Medical Center from 2010 to 2025. Earlier, she served at Şişli and Gayrettepe Florence Nightingale Hospitals. She completed her general surgery training at SSK Okmeydanı from 2000 to 2006. She earned her MD from Marmara University, ranking 12th in her class. She also trained in GI surgery for inflammatory bowel disease at the University of Florence in August 2000.
Her research focuses on prognostic factors in breast and colorectal cancer. She wrote a melanoma thesis in 2006 and co-authored papers in Cancer (2005), Breast (2006, 2014), Annals of Surgical Oncology (2008), The Breast Journal (2011), ISRN Oncology (2011), Japanese Journal of Clinical Oncology (2012), World Journal of Surgery (2013; 2,151 patients), International Journal of Surgery (2014), and Journal of Gastrointestinal Cancer (2017).
Dr. Cesar Levano Linares is a specialist in digestive surgery with a PhD from the Autonomous University of Madrid. He provides expert online consultations for surgical planning and digestive health.
Professor Klaus Kaczirek is a senior surgeon at Vienna General Hospital. He leads the liver and pancreas surgical group for the Austrian Society of Surgical Oncology.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.
Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center. He provides online consultation with Surgeon for complex prostate, kidney, and bladder cancers.
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
OA Dr. med. Peter Guglia is a specialist in orthopaedics and orthopaedic surgery at JUVENIS. He is also a senior physician at the Spine Centre, Orthopaedic Hospital Speising, Austria’s leading orthopaedic hospital. He has over 30 years of experience. His work focuses on non-surgical diagnosis, pain therapy, and movement and posture assessment.
MD 1991. General medicine training 1994–1997. Specialist diploma in orthopaedics and orthopaedic surgery 1997–2003. This dual training enables a whole‑patient assessment.
Career: Resident, University Department of Orthopaedics, AKH Vienna (2002–2003). Senior physician and deputy head, SKA Zicksee (2003–2012). Senior physician, Speising Spine Centre (2012–present). JUVENIS (2012–present). Clinical focus includes conservative orthopaedics, classical and complementary pain medicine, movement and posture analysis, preventive exams, and insurance medicine, including independent assessments. He also provides independent second opinions on the need for spine surgery.
Dr. Dr. med. Bernhard Moser is a double board-certified surgeon at JUVENIS Medical Center in Vienna. He is a specialist in plastic and aesthetic surgery and in oral, maxillofacial, and facial surgery. He also holds additional qualifications in hand, plastic, and microsurgery, and a DEGUM Level 1 diagnostic ultrasound certificate.
He completed residency training at UKSH Kiel from 2014 to 2016. He became a specialist in oral and maxillofacial surgery in 2017 and in hand, plastic, and microsurgery in 2017 at UKSH. He qualified as a specialist in plastic and aesthetic surgery in 2021. He served as a senior physician at Agaplesion Diakonieklinikum Rotenburg from 2018 to 2021. He was lead physician at Bergman Clinics Germany from 2021 to 2023. He joined JUVENIS in 2024.
He has been active in microsurgical research at Kiel University since 2015. He founded flaplab.org in 2018. His clinical focus includes rhinoplasty, hand and nerve surgery, and microsurgery. He also performs aesthetic and reconstructive facial, breast, and body-contouring surgery, burn surgery, and liposuction and lipofilling. He treats patients in German, English, Russian, and Spanish.
The doctor is a highly specialized surgeon with extensive expertise in head and neck surgery, focusing on the surgical treatment of malignancies within this region. The clinical practice encompasses a broad spectrum of procedures, including endoscopic sinus surgeries and advanced microsurgical techniques for head and neck diseases.
Furthermore, the doctor provides comprehensive care for patients suffering from hearing loss, ear-related pathologies, and various salivary gland disorders. Additional clinical focus areas include the management and surgical intervention of dizziness and vertigo, ensuring a multidisciplinary approach to complex otolaryngological conditions.
Dr. Mehmet Hakan Tekelioglu is a general surgeon at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in thyroid surgery and bariatric procedures. Dr. Tekelioglu conducted research on TSH suppression at Istanbul University Cerrahpasa Faculty of Medicine. He works at a JCI-accredited facility known for its high patient safety standards.
The doctor is a highly specialized surgeon with extensive expertise in oncological and metabolic procedures. The clinical focus encompasses a wide range of cancer surgeries, including complex interventions for pancreatic, bile duct, gastric, colon, and thyroid malignancies, as well as specialized breast surgery.
In addition to oncology, the doctor is proficient in bariatric and metabolic surgery, providing advanced surgical solutions for obesity and diabetes management. The practice is dedicated to delivering comprehensive surgical care, utilizing evidence-based techniques to address both malignant conditions and metabolic health disorders.
The doctor is a highly skilled specialist in both adult and pediatric ENT diseases, offering comprehensive care for a wide range of ear, nose, and throat conditions. Clinical expertise includes advanced endoscopic and microscopic middle ear surgeries, as well as specialized procedures for sleep apnea and snoring.
In addition to functional ENT treatments, the doctor performs various plastic surgery procedures, including rhinoplasty and protruding ear correction. The practice also incorporates aesthetic medicine, providing professional filling and Botox treatments. Furthermore, the doctor utilizes the modern plasma-evaporation method for tonsil and adenoid operations, ensuring precise and effective surgical outcomes for patients.
Dr. Pasu Promniyom is a plastic surgeon at W Plastic Surgery Hospital in Bangkok. He is a specialist at King Chulalongkorn Memorial Hospital and holds a Diploma of the Thai Board of Plastic Surgery. He earned his medical degree with honors from Chulalongkorn University. He performs facial rejuvenation and body contouring using surgical and device-assisted methods.
Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.
From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.
Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.
Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.
He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.
Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.